ChromaDex Debuts Clinical Strength Tru Niagen® Pro 1,000mg Featuring Niagen® (Patented Nicotinamide Riboside), One of the Most Efficient Nicotinamide Adenine Dinucleotide (NAD+) Boosters Available, to Consumers Nationwide
Retrieved on:
Wednesday, November 1, 2023
Vitamins, Supplements, Other Retail, Marketing, Fitness & Nutrition, Communications, Specialty, Health, Retail, Influencer, OBGYN, Nicotinamide adenine dinucleotide, Ageing, NSF International, Major League Baseball, Senior ice hockey, Depression, NAD, Internet, Physician, ChromaDex, National Hockey League, Host, Bureau of Oceans and International Environmental and Scientific Affairs, Research, Multimedia, Senior, MLB, USADA, Nobel Prize, NHL, Safety, NR, Dietary supplement, Medical device, Nicotinamide riboside, RD, Habit
ChromaDex Corp. (NASDAQ:CDXC), a global authority on Nicotinamide Adenine Dinucleotide (NAD+) research and healthy aging, launches its clinical strength Tru Niagen® Pro 1,000mg , featuring 1,000mg of Niagen® (patented Nicotinamide Riboside or NR), one of the most efficient and superior quality NAD+ precursors on the market, to consumers nationwide.
Key Points:
- ChromaDex Corp. (NASDAQ:CDXC), a global authority on Nicotinamide Adenine Dinucleotide (NAD+) research and healthy aging, launches its clinical strength Tru Niagen® Pro 1,000mg , featuring 1,000mg of Niagen® (patented Nicotinamide Riboside or NR), one of the most efficient and superior quality NAD+ precursors on the market, to consumers nationwide.
- With 1,000mg of Niagen used in over 50% of published clinical studies, this serving is redefining research for NAD+ related health outcomes.
- “As a pioneer of NAD+ research, our team works with esteemed investigators across the globe to uncover the full potential of NAD+.
- Tru Niagen Pro 1,000mg was unveiled to a select group of Key Opinion Leaders (KOLs), physicians, influencers and celebrities at the Tru Niagen Wellness Retreat in Malibu last week.